Santen Pharmaceutical Co., Ltd. earnings per share and revenue

SNPHF earnings per share for the last quarter are 0.11 USD whereas the estimation was 0.12 USD which accounts for -6.51% surprise. Company revenue for the same period amounts to 536.63 M USD despite the estimated figure of 522.87 M USD. Estimated earnings per share for the next quarter are 0.14 USD, and revenue is expected to reach 433.68 M USD. Also watch annual changes over time to get a bigger picture of SNPHF earnings per share and revenue dynamics.